Melagenin Plus®: Cuba's Placental Histotherapy for Vitiligo
Melagenin Plus® is a topical medication developed at Cuba's Placental Histotherapy Center. It is derived from human placenta and contains a lipoprotein fraction that stimulates melanocyte proliferation and melanin production. The treatment aims to repigment affected skin areas.
Treatment involves daily application of Melagenin Plus® to affected areas, followed by controlled exposure to sunlight or phototherapy. The treatment is painless and non-invasive, making it suitable for patients of all ages and skin types. Treatment cycles typically last several weeks.
Cuba's approach may also include Coriodermina® for related skin conditions and other placental histotherapy products. The dermatology team monitors progress throughout treatment and adjusts the protocol as needed. Best results are typically seen in patients with stable vitiligo affecting limited body areas.
All Sections — Vitiligo
Medically Reviewed
Dr. Ana Fernández
MD, Dermatology — Havana Dermatology Center
Last reviewed: July 3, 2026
Medical References
- [1]Cuba's Placental Histotherapy Center. Melagenin Plus® Clinical Documentation.
- [2]American Academy of Dermatology. Vitiligo: Diagnosis and Treatment.
- [3]Vitiligo Research Foundation. Vitiligo Facts and Statistics.
This content has been medically reviewed by qualified physicians and follows SMC Salud's editorial policy for health information. Medical content is for informational purposes and does not replace professional medical advice.
Begin Your Path to Healing
Submit your inquiry and our international patient coordination team will review your case and respond within 24–48 hours with a personalized treatment recommendation.